Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives.
about
Analysis and characterization of heparin impuritiesGlycosaminoglycans detection methods: Applications of mass spectrometry.Effect of carboxyl-reduced heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells.Microscale isolation and analysis of heparin from plasma using an anion-exchange spin columnCharacterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns.Pharmacokinetics and pharmacodynamics of oral heparin solid dosage form in healthy human subjects.Preparation and structural determination of large oligosaccharides derived from acharan sulfateDromedary glycosaminoglycans: molecular characterization of camel lung and liver heparan sulfateBinding between the integrin alphaXbeta2 (CD11c/CD18) and heparinPhotochemical Preparation of a Novel Low Molecular Weight HeparinChemoenzymatic synthesis of homogeneous ultralow molecular weight heparinsGlycosaminoglycans of the porcine central nervous systemHeparin mapping using heparin lyases and the generation of a novel low molecular weight heparinImpact of autoclave sterilization on the activity and structure of formulated heparin.Mass balance analysis of contaminated heparin product.Structural characterization of heparins from different commercial sourcesAnti-proliferative effects of O-acyl-low-molecular-weight heparin derivatives on bovine pulmonary artery smooth muscle cells.A structural analysis of glycosaminoglycans from lethal and nonlethal breast cancer tissues: toward a novel class of theragnostics for personalized medicine in oncology?Domain structure elucidation of human decorin glycosaminoglycans.Analysis of E. coli K5 capsular polysaccharide heparosan.Thin-layer chromatography for the analysis of glycosaminoglycan oligosaccharidesMosquito heparan sulfate and its potential role in malaria infection and transmission.Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS.Analysis of glycosaminoglycans in stem cell glycomics.Significance of the 2-O-sulfo group of L-iduronic acid residues in heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells.Isolation and structural characterization of glycosaminoglycans from heads of red salmon (Oncorhynchus nerka).Is human placenta proteoglycan remodeling involved in pre-eclampsia?Oversulfated chondroitin sulfate: impact of a heparin impurity, associated with adverse clinical events, on low-molecular-weight heparin preparation.Structural characterization of glycosaminoglycans from zebrafish in different agesSulfonation of papain-treated chitosan and its mechanism for anticoagulant activity.Distinct heparan sulfate compositions in wild-type and pipe-mutant eggshell matrixStructure and activity of a new low-molecular-weight heparin produced by enzymatic ultrafiltration.Microbial heparin/heparan sulphate lyases: potential and applications.Oxidation of glycosaminoglycans by free radicals and reactive oxidative species: A review of investigative methods.Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma.Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor.Agarose and polyacrylamide gel electrophoresis methods for molecular mass analysis of 5- to 500-kDa hyaluronan.Synthetic oligosaccharide stimulates and stabilizes angiogenesis: structure-function relationships and potential mechanisms.Increase in the growth inhibition of bovine pulmonary artery smooth muscle cells by an O-hexanoyl low-molecular-weight heparin derivative.Interaction of heparin with synthetic antithrombin III peptide analogues.
P2860
Q24605666-13C1E412-7400-4F10-8E04-7BBD931C29A2Q33816146-299A4888-731B-416E-B793-3C52A6371610Q33939401-B19F2D92-7C5E-49F2-AC3F-4C4CAD92495DQ33994681-262D9CD9-4366-4287-B21C-99D561452DC9Q34013926-620886F1-3C82-477E-BD7E-D21F941933A5Q34056269-AB870D55-1B13-4DC4-809D-8324CDB14587Q34075020-F974E25D-D6E5-4DAA-B0DF-DE309D0A21C4Q34081506-0B824396-EC31-4960-8149-5AAADFBB6961Q34081557-97716F76-A55C-4FF5-A0C4-C227EA200FA5Q34113419-5ECA8C44-33BB-47AA-A0B2-1B035DD9715EQ34228210-60C2498C-00FD-4B57-8964-AB7B0C433BB2Q34296703-91579EAF-BAEA-433D-A03F-37020A45482BQ34507805-5AF6F8E1-5BA3-4E89-ACDD-A3664785BC99Q35185938-3D0C351D-CB1A-4591-8FDD-983D16B48EC0Q35234372-FA765320-8891-456B-94F0-20BCA9EFE850Q35488687-8ED400EE-E621-4B89-AC09-D7C62E2684DBQ35603850-B131FACC-4947-4E1D-B8F6-23A78C97A4BEQ35823840-81F8D1A0-075E-457E-A406-D85A981D62DCQ35984160-89E111E9-17E5-4693-B02D-6B729056F6C3Q36077519-01BE7EBB-91C6-4886-AC9C-4F7ACBE3D14EQ36120831-FA4502B6-C702-436E-9E88-67B537C7ADCAQ36238824-CB2B5106-234B-461F-BAC6-89B1742FE751Q36343123-BC9E2938-8E96-4910-AB24-239806772331Q36401922-38A8B56E-7B78-4977-A310-F194C8ADC2FEQ36556537-A34C186A-63C1-4943-B434-8A9119CA6935Q36608582-2C87E5B5-6B80-4A12-A91F-938CA37CD910Q37070872-E40B8A19-A15D-43E5-8E61-142154D6D7C7Q37071056-B79D23A7-00B1-4B8A-BE7E-3F983507E21FQ37098736-747E4ED1-177A-4E8A-9157-1CC6C8BDC087Q37306987-693FBCA3-EE6D-4C9E-BBAD-109398B303EAQ37442484-26769A6B-F404-4BA7-ADE0-06456D86C063Q37721780-BC0EB039-A559-46D0-8A88-F5E69E856061Q37990767-8DCFA6DC-B1D8-460F-ABEA-CEE0B7F55B95Q38269754-E057BF4B-5344-481B-B1C9-4E1EDB3EC704Q38337031-F26A6275-7E26-4F9F-9DD3-25F4EF5A3BCBQ38349679-02BB3C8F-6C4D-4672-B129-50DE2E1D5864Q38931714-5EF2EEF0-B4DF-416C-AC31-7D2825342F2EQ40290927-437DCCB8-BCFE-45FA-B812-F9FF80D3B4F0Q40296024-B842D099-C117-4C0D-9AFF-4A8AEA3DF797Q41763091-FCEF1B88-A7DC-4340-9067-7268DA684559
P2860
Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Gradient polyacrylamide gel el ...... ar-weight heparin derivatives.
@en
Gradient polyacrylamide gel el ...... ar-weight heparin derivatives.
@nl
type
label
Gradient polyacrylamide gel el ...... ar-weight heparin derivatives.
@en
Gradient polyacrylamide gel el ...... ar-weight heparin derivatives.
@nl
prefLabel
Gradient polyacrylamide gel el ...... ar-weight heparin derivatives.
@en
Gradient polyacrylamide gel el ...... ar-weight heparin derivatives.
@nl
P2093
P356
P1476
Gradient polyacrylamide gel el ...... ar-weight heparin derivatives.
@en
P2093
P304
P356
10.1002/JPS.2600810821
P407
P577
1992-08-01T00:00:00Z